Zosyn and Peridex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zosyn (piperacillin sodium; tazobactam sodium) and Peridex (chlorhexidine gluconate). Common drug interactions include atelectasis among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Zosyn and Peridex. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Zosyn?

Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.

What is Peridex?

Peridex has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 2,803 Peridex users. Check the latest studies of Peridex.



On Jul, 16, 2026

93 people who take Zosyn and Peridex together, and have interactions are studied.

Zosyn and Peridex drug interactions.

What are the common drug interactions of Zosyn and Peridex, by gender? *:

female:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Anxiety
  6. Back pain
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dyspnoea (difficult or laboured respiration)
  10. Loss of consciousness

male:

  1. Back pain
  2. Pain in extremity
  3. Mouth ulceration (mouth ulcers)
  4. Nephrolithiasis (calculi in the kidneys)
  5. Oral herpes (viral infection of mouth)
  6. Sinus disorder (disease of sinus)
  7. Tooth infection
  8. Lichen planus (an inflammatory skin condition, characterized by an itchy, non-infectious rash)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Tooth fracture

What are the common drug interactions of Zosyn and Peridex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anaemia (lack of blood)
  2. Back pain
  3. Delayed engraftment
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  6. Headache (pain in head)
  7. Hyperbilirubinaemia (excess of bilirubin in the blood)
  8. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  9. Hypotension (abnormally low blood pressure)
  10. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

10-19:

  1. Bradycardia (abnormally slow heart action)
  2. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  3. Hypoxia (low oxygen in tissues)
  4. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  5. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  6. Appetite disorder (abnormal eating habits)
  7. Blood creatinine increased
  8. Blood lactic acid increased
  9. Blood urea increased
  10. Bone marrow failure

20-29:

  1. Alopecia (absence of hair from areas of the body)
  2. Anaemia (lack of blood)
  3. Arthralgia (joint pain)
  4. Brain compression
  5. Breast cancer stage iii
  6. Breast fibrosis (the thickening and scarring of connective tissue, usually as a result of injury in breast)
  7. Breast inflammation
  8. Cerebellar infarction (impaired blood circulation to cerebellum)
  9. Dental caries
  10. Dermoid cyst (an abnormal growth (teratoma) containing epidermis, hair follicles, and sebaceous glands)

30-39:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
  3. Headache (pain in head)

40-49:

  1. Diarrhoea
  2. Anxiety
  3. Back pain
  4. Bone disorder
  5. Bone pain
  6. Cellulitis (infection under the skin)
  7. Injury
  8. Mouth ulceration (mouth ulcers)
  9. Nephrolithiasis (calculi in the kidneys)
  10. Oral herpes (viral infection of mouth)

50-59:

  1. Osteonecrosis of jaw (death of bone of jaw)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Physical disability
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Urinary tract infection
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Abdominal pain
  9. Cardiac failure congestive
  10. Cellulitis (infection under the skin)

60+:

  1. Cellulitis (infection under the skin)
  2. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Anaemia (lack of blood)
  5. Anxiety
  6. Atelectasis (partial or complete collapse of the lung)
  7. Back pain
  8. Death
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the existing conditions these people have? *

  1. High Blood Pressure: 14 people, 15.05%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 12 people, 12.90%
  3. Nausea (feeling of having an urge to vomit): 12 people, 12.90%
  4. Sedation: 9 people, 9.68%
  5. Pain: 9 people, 9.68%
  6. Constipation: 9 people, 9.68%
  7. Dyspnea (difficult or laboured breathing): 9 people, 9.68%
  8. Cough: 8 people, 8.60%
  9. Multiple Myeloma (cancer of the plasma cells): 8 people, 8.60%
  10. Diarrhea: 7 people, 7.53%

* Approximation only. Some reports may have incomplete information.

Do you take Zosyn and Peridex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zosyn and Peridex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Peridex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Peridex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on piperacillin sodium; tazobactam sodium and chlorhexidine gluconate (the active ingredients of Zosyn and Peridex, respectively), and Zosyn and Peridex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: